40
Participants
Start Date
May 15, 2023
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Scrambler Therapy
"Scrambler Therapy is a non-invasive neuromodulator treatment that focuses on relieving chronic pain through the sending of non-pain signals to the brain through the afferent pain sensory nerves. The signals given off by the scrambler therapy machine are intended to mimic neuronal action potentials through the synthesis of 16 unique waveforms that in combination forms a patient specific cutaneous electrostimulation to reduce pain. These information packets are then carried by the afferent C-fibers, an established system that modulates the sensations received instead of blocking them. The modulated signals are received as nonpainful and endogenous by the central nervous system."
Standard Medication Management
Medications such as: gabapentin, duloxetine and Lyrica are all FDA approved for treatment of neuropathic pain, particularly that caused by diabetes.
RECRUITING
Johns Hopkins Bayview Hospital, Baltimore
Johns Hopkins University
OTHER